Recent insider trading activity from Rothera Mark, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 12, 2024 | Viracta Therapeutics, Inc. | $VIRX | Rothera Mark | President and CEO | A | Stock Option (Right to Buy) | 475000 | $0.00 | 475,000.0000 | 39,272,434 | 9999.99% | 1.21% |